Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide.

Autor: Bhattacharya, Udayan1 (AUTHOR), Kamran, Mohammad1 (AUTHOR), Manai, Maroua2 (AUTHOR), Cristofanilli, Massimo2 (AUTHOR), Ince, Tan A.1,3 (AUTHOR) tai9015@med.cornell.edu
Zdroj: Cancers. Jan2023, Vol. 15 Issue 2, p332. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje